Isopyropanol
Isopyropanol
12
Revision Date 05.02.2024
according to Regulation (EC) No. 1907/2006 Print Date 09.05.2025
GENERIC EU MSDS - NO COUNTRY SPECIFIC DATA - NO OEL DATA
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances
1.3 Details of the supplier of the safety data sheet
Company : Sigma-Aldrich Chemie GmbH
Eschenstrasse 5
D-82024 TAUFKIRCHEN
Telephone : +49 (0)89 6513-1130
Fax : +49 (0)89 6513-1161
E-mail address : [email protected]
1.4 Emergency telephone
Ecological information:
The substance/mixture does not contain components considered to have endocrine
disrupting properties according to REACH Article 57(f) or Commission Delegated regulation
(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Toxicological information:
The substance/mixture does not contain components considered to have endocrine
disrupting properties according to REACH Article 57(f) or Commission Delegated regulation
(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Formula : C3H8O
Molecular weight : 60,10 g/mol
CAS-No. : 67-63-0
EC-No. : 200-661-7
Index-No. : 603-117-00-0
Component Classification Concentration
2-Propanol
CAS-No. 67-63-0 Flam. Liq. 2; Eye Irrit. 2; <= 100 %
EC-No. 200-661-7 STOT SE 3; H225, H319,
Index-No. 603-003-00-0 H336
Concentration limits:
>= 20 %: STOT SE 3,
H336;
For the full text of the H-Statements mentioned in this Section, see Section 16.
Eye/face protection
Use equipment for eye protection tested and approved under appropriate
government standards such as NIOSH (US) or EN 166(EU). Safety glasses
Skin protection
This recommendation applies only to the product stated in the safety data sheet,
supplied by us and for the designated use. When dissolving in or mixing with other
Headache
Dizziness
inebriation
Unconsciousness
narcosis
Coma